{"id":5564,"date":"2020-08-13T21:51:12","date_gmt":"2020-08-13T11:51:12","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?page_id=5564"},"modified":"2024-12-24T14:03:59","modified_gmt":"2024-12-24T03:03:59","slug":"breastfeeding-and-immunisations","status":"publish","type":"references","link":"https:\/\/mvec.mcri.edu.au\/hi\/references\/breastfeeding-and-immunisations\/","title":{"rendered":"Breastfeeding and vaccines"},"content":{"rendered":"
<\/p>\n

\u092a\u0943\u0937\u094d\u0920\u092d\u0942\u092e\u093f<\/h2>\n

Most vaccines can safely be administered to people who are breastfeeding.<\/span><\/p>\n

Receiving vaccines while breastfeeding offers the benefits of both getting protection from certain vaccine-preventable diseases and decreasing the potential of transmitting the diseases to others (including the infant). Additionally, maternal antibodies have been found in breastmilk suggesting that some passive immunity (short-term protection from donated antibodies) can also be transferred to the infant.<\/span><\/p>\n

Vaccinating people who are breastfeeding does not diminish the volume or quality of breastmilk produced. Conversely, lactation can be impacted when a breastfeeding person becomes unwell (such as with a vaccine-preventable disease).<\/span><\/p>\n

Recommendations<\/h2>\n

People who are breastfeeding should be up to date with the vaccines recommended on the \u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u091f\u0940\u0915\u093e\u0915\u0930\u0923 \u0915\u093e\u0930\u094d\u092f\u0915\u094d\u0930\u092e (NIP)<\/a>. Additional risk factors such as travel<\/a>, occupation and underlying medical conditions<\/a> may also mean that further vaccines or additional doses are recommended.<\/span><\/p>\n

A person does not need to stop breastfeeding before or after they receive a vaccine.<\/span><\/p>\n

Where a \u0917\u0930\u094d\u092d\u0935\u0924\u0940<\/a> person has been found to be seronegative (not immune) to \u0916\u0938\u0930\u093e<\/a>, mumps, rubella or \u0935\u0948\u0930\u0940\u0938\u0947\u0932\u093e<\/a>, these vaccines can be administered post-partum while breastfeeding (noting that live-attenuated<\/a> vaccines are contraindicated during pregnancy).<\/span><\/p>\n

People who are breastfeeding should be up to date with the current annual

<\/div><\/a> vaccine. If they did not receive any influenza vaccine while pregnant, or if the influenza vaccine they received during pregnancy was for the previous year\u2019s influenza season, they should be vaccinated while breastfeeding. Vaccination protects both the vaccine recipient and the breastfeeding infant. This is important to provide some protection to the infant before they can receive their own influenza vaccination from 6 months of age.<\/span><\/p>\n

\u090f\u0939\u0924\u093f\u092f\u093e\u0924<\/h2>\n

Rubella<\/h3>\n

It is <\/span>safe to administer rubella vaccines to people who are breastfeeding.<\/span> In rare cases the live-attenuated <\/span>\u091f\u0940\u0915\u093e <\/span>virus may be secreted in breastmilk<\/span>. <\/span>If this occurs, the b<\/span>reastfeeding i<\/span>

<\/div><\/span>fant<\/span> may experience <\/span>mild symptoms <\/span>associated<\/span> with<\/span> rubella<\/span> \u092f\u093e<\/span> no <\/span>symptoms at all. For more information, go to Australian Immunisation Handbook: Rubella<\/a>.<\/span><\/span><\/p>\n

\u0939\u0947\u092a\u0947\u091f\u093e\u0907\u091f\u093f\u0938 \u092c\u0940<\/h3>\n

It is safe for a person who is positive for the \u0939\u0947\u092a\u0947\u091f\u093e\u0907\u091f\u093f\u0938 \u092c\u0940<\/a> virus to breastfeed their infant as long as the infant has received hepatitis B immunoglobulin (HBIG) and a birth dose of hepatitis B vaccine. These are recommended, and ideally administered on the day of birth (preferably within 12 hours), at the same time, in separate thighs. HBIG needs to be administered within 48 hours after birth (efficacy is significantly reduced if administration is delayed > 48 hours after birth) and the vaccine up to 7 days after birth. The routine scheduled 3 dose course of hepatitis B vaccine should also be completed at 6 weeks, 4 months and 6 months (as per the NIP).<\/span>\u00a0<\/span><\/p>\n

The infant should have serology performed 3 to 12 months post the 6-month dose of hepatitis B vaccine.<\/span><\/p>\n

\u092a\u0940\u0932\u093e \u092c\u0941\u0916\u093e\u0930<\/h3>\n

Administering \u092a\u0940\u0932\u093e \u092c\u0941\u0916\u093e\u0930<\/a> vaccines to people who are breastfeeding infants less than 9 months of age should be avoided due to the potential transfer of the live-attenuated vaccine virus through breastmilk. Younger infants (< 9 months of age) have a greater risk of developing yellow fever vaccine-associated neurotropic disease (YF-AND), a serious adverse event that can occur following yellow fever vaccination.<\/span><\/p>\n

Individual advice should be sought from a travel\/immunisation specialist if a breastfeeding person cannot avoid or delay travel to a yellow fever endemic area. If the benefits of vaccination outweigh the risks, then vaccination can be considered.<\/span><\/p>\n

Access<\/h2>\n

Vaccines can be administered through local council immunisation services, accredited pharmacies, GP clinics and Aboriginal Health Services.<\/span><\/p>\n

Influenza vaccines are not funded for breastfeeding people who do not have additional risk factors but can be privately purchased via their provider.<\/span><\/p>\n

\u0906\u092e\u0924\u094c\u0930 \u092a\u0930 \u092a\u0942\u091b\u0947 \u091c\u093e\u0928\u0947 \u0935\u093e\u0932\u0947 \u092a\u094d\u0930\u0936\u094d\u0928<\/h2>\n

\n<\/div>